Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia ; volume:19 ; number:1 ; day:14 ; month:1 ; year:2020 ; pages:1-7 ; date:12.2020
Annals of general psychiatry ; 19, Heft 1 (14.1.2020), 1-7, 12.2020
- Creator
-
Kim, Hye Ok
Seo, Gi Hyeon
Lee, Boung Chul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12991-019-0254-2
- URN
-
urn:nbn:de:101:1-2020041919431961944144
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Hye Ok
- Seo, Gi Hyeon
- Lee, Boung Chul
- SpringerLink (Online service)
Other Objects (12)
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
The cost associated with administering risperidone long-acting injections in the Australian community
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Reversible Contraception
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study
Development of long-acting ARV’s
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
The cost associated with administering risperidone long-acting injections in the Australian community
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Reversible Contraception
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study
Development of long-acting ARV’s
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections
The cost associated with administering risperidone long-acting injections in the Australian community
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Long-Acting Reversible Contraception
Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study
Development of long-acting ARV’s
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics